HealthMEDX bought by equity firms
Spectrum Equity Investors, a private equity firm, and Trident Capital, a venture capital firm, have acquired long term and post-acute care technology provider HealthMEDX.
In connection with the acquisition, Pamela Pure, former president of McKesson Technology, has joined HealthMEDX as its CEO. Vince Estrada, former senior vice president of business development and chief financial officer of Visicu will join as executive vice president of business development and chief financial officer.
HealthMEDX co-founder Charlie Daniels will remain as president and co-founder Dan Cobb will remain as chief technology officer. Co-founder Jim Atteberry will serve as a strategic advisor.
The transaction provides liquidity to the company’s founders, as well as access to additional capital for investment in new products and future acquisitions, Spectrum and Trident stated. Financial terms of the transaction were not disclosed.
As part of the transaction, Jim Quagliaroli and Steve LeSieur of Spectrum Equity, Arneek Multani and John Reardon of Trident Capital, and Pamela Pure will comprise HealthMEDX’s board of directors.
In connection with the acquisition, Pamela Pure, former president of McKesson Technology, has joined HealthMEDX as its CEO. Vince Estrada, former senior vice president of business development and chief financial officer of Visicu will join as executive vice president of business development and chief financial officer.
HealthMEDX co-founder Charlie Daniels will remain as president and co-founder Dan Cobb will remain as chief technology officer. Co-founder Jim Atteberry will serve as a strategic advisor.
The transaction provides liquidity to the company’s founders, as well as access to additional capital for investment in new products and future acquisitions, Spectrum and Trident stated. Financial terms of the transaction were not disclosed.
As part of the transaction, Jim Quagliaroli and Steve LeSieur of Spectrum Equity, Arneek Multani and John Reardon of Trident Capital, and Pamela Pure will comprise HealthMEDX’s board of directors.